Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellis W Lader

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Annals of Internal Medicine|April 3, 2023
After PCI and 6 to 18 mo of DAPT, clopidogrel reduced a composite of clinical events vs. aspirin at 6 yEllis W Lader
Annals of Internal Medicine|January 2, 2023
In rheumatic heart disease-associated AF, rivaroxaban increased adverse vascular outcomes vs. VKA at 3 yEllis W Lader
Lancet (London, England)|September 21, 2002
Acronym maniaEllis W Lader
The American Journal of Cardiology|June 1, 2019
Type 2 Myocardial Infarction: Trying to Fit a Square Peg Into a Round Hole?Ellis W Lader
Annals of Internal Medicine|March 3, 2025
In previous MI with ventricular tachycardia (VT), catheter ablation reduced mortality or VT events more than antiarrhythmic drug therapy at 4 yEllis W Lader,
Critical Pathways in Cardiology|March 15, 2008
How to join a clinical trialEllis W Lader, Christopher P Cannon
Circulation|June 3, 2004
The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysisEllis W Lader, Christopher P Cannon, E Magnus Ohman, et al.
Circulation|June 3, 2004
The clinician as investigator: participating in clinical trials in the practice settingEllis W Lader, Christopher P Cannon, E Magnus Ohman, et al.
Circulation|June 3, 2004
The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study designEllis W Lader, Christopher P Cannon, E Magnus Ohman, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Annals of Internal Medicine|April 3, 2023
After PCI and 6 to 18 mo of DAPT, clopidogrel reduced a composite of clinical events vs. aspirin at 6 yEllis W Lader
Annals of Internal Medicine|January 2, 2023
In rheumatic heart disease-associated AF, rivaroxaban increased adverse vascular outcomes vs. VKA at 3 yEllis W Lader
Lancet (London, England)|September 21, 2002
Acronym maniaEllis W Lader
The American Journal of Cardiology|June 1, 2019
Type 2 Myocardial Infarction: Trying to Fit a Square Peg Into a Round Hole?Ellis W Lader
Annals of Internal Medicine|March 3, 2025
In previous MI with ventricular tachycardia (VT), catheter ablation reduced mortality or VT events more than antiarrhythmic drug therapy at 4 yEllis W Lader,
Critical Pathways in Cardiology|March 15, 2008
How to join a clinical trialEllis W Lader, Christopher P Cannon
Circulation|June 3, 2004
The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysisEllis W Lader, Christopher P Cannon, E Magnus Ohman, et al.
Circulation|June 3, 2004
The clinician as investigator: participating in clinical trials in the practice settingEllis W Lader, Christopher P Cannon, E Magnus Ohman, et al.
Circulation|June 3, 2004
The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study designEllis W Lader, Christopher P Cannon, E Magnus Ohman, et al.
Pageof 1